Hangzhou Coco Healthcare Products Co.,Ltd.
Symbol: 301009.SZ
SHZ
9.21
CNYTržní cena dnes
89.9693
Poměr P/E
0.0000
Poměr PEG
2.50B
MRK Cap
- 0.00%
Výnos DIV
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 863.1 | 689.5 | 884 | |||||||
balance-sheet.row.short-term-investments | 0 | -20.4 | -21.2 | -23.5 | |||||||
balance-sheet.row.net-receivables | 0 | 213 | 274.5 | 188.2 | |||||||
balance-sheet.row.inventory | 0 | 114.8 | 182.4 | 153.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 13.9 | 12.2 | 27.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 1204.7 | 1158.5 | 1253.8 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 663.4 | 670.4 | 694.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.long-term-investments | 0 | 30.1 | 21.5 | 23.7 | |||||||
balance-sheet.row.tax-assets | 0 | 10.1 | 8.2 | 2.1 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | 5.2 | 24.2 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 787.3 | 790.1 | 831.8 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.account-payables | 0 | 439 | 429.9 | 528.5 | |||||||
balance-sheet.row.short-term-debt | 0 | 6.2 | 1.4 | 1.5 | |||||||
balance-sheet.row.tax-payables | 0 | 5.5 | 6.5 | 1.4 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 11.9 | 3.3 | 5.1 | |||||||
Deferred Revenue Non Current | 0 | 45.2 | 39.1 | 6.8 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.6 | 0.8 | 0.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 57.1 | 42.3 | 11.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.9 | 3.3 | 5.1 | |||||||
balance-sheet.row.total-liab | 0 | 542.4 | 516.9 | 578.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 271.9 | 271.9 | 271.9 | |||||||
balance-sheet.row.retained-earnings | 0 | 300.4 | 284.3 | 348.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 73.2 | 70.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 800.4 | 723.2 | 723.2 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1372.7 | 1352.6 | 1414.7 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.minority-interest | 0 | 76.9 | 79.2 | 92.3 | |||||||
balance-sheet.row.total-equity | 0 | 1449.6 | 1431.8 | 1507 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 9.7 | 0.3 | 0.3 | |||||||
balance-sheet.row.total-debt | 0 | 18.1 | 4.6 | 6.6 | |||||||
balance-sheet.row.net-debt | 0 | -845 | -684.8 | -877.4 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | 0 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | 0 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | 0 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 0 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | 0 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 0 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | 0 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 0 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 0 | -153.6 | -189.9 | 175.1 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1081.5 | 1186.3 | 1186.4 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 890.6 | 1030.9 | 965.3 | |||||||
income-statement-row.row.gross-profit | 0 | 190.9 | 155.4 | 221.1 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.operating-expenses | 0 | 175.2 | 171.3 | 176.8 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 1065.7 | 1202.2 | 1142.1 | |||||||
income-statement-row.row.interest-income | 0 | 24.2 | 23.3 | 12.6 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 56.8 | 61.3 | 49.4 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 20.2 | -55.5 | 45.3 | |||||||
income-statement-row.row.income-before-tax | 0 | 19.5 | -56.4 | 43.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 1.7 | -0.1 | 4.1 | |||||||
income-statement-row.row.net-income | 0 | 20.2 | -43.1 | 39.7 |
Často kladené otázky
Co je Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) celková aktiva?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) celková aktiva jsou 1992017074.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.187.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 0.539.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.026.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.028.
Co je Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 20184911.000.
Jaký je celkový dluh podniku?
Celkový dluh je 18052009.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 175169142.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.